{"altmetric_id":1894230,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["546410588769082"],"posts_count":2},"total":{"posts_count":2}},"citation":{"altmetric_jid":"4f6fa4d23cf058f610000dcd","authors":["Michal R. Pijak"],"doi":"10.1503\/cmaj.1060092","first_seen_on":"2013-11-09T18:09:50+00:00","issns":["0820-3946","1488-2329"],"issue":"1","journal":"Canadian Medical Association Journal","last_mentioned_on":1385929374,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1482764\/","http:\/\/www.cmaj.ca\/content\/175\/1\/63.2.full"],"pmid":"16818917","pubdate":"1970-01-01T01:00:00+00:00","publisher":"Canadian Medical Association","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"63","subjects":["medicine"],"title":"Hepatitis C: reviewing the options","type":"article","volume":"175"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":3627464,"mean":4.9483847763613,"rank":2906243,"this_scored_higher_than_pct":2,"this_scored_higher_than":74100,"rank_type":"exact","sample_size":3627464,"percentile":2},"similar_age_3m":{"total_number_of_other_articles":97423,"mean":7.7212542752152,"rank":77286,"this_scored_higher_than_pct":1,"this_scored_higher_than":278,"rank_type":"exact","sample_size":97423,"percentile":1},"this_journal":{"total_number_of_other_articles":3178,"mean":11.722683663834,"rank":2786,"this_scored_higher_than_pct":1,"this_scored_higher_than":62,"rank_type":"exact","sample_size":3178,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":53,"mean":14.777076923077,"rank":47,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":53,"percentile":1}}},"demographics":[],"posts":{"facebook":[{"title":"Hepatitis C: reviewing the options","url":"https:\/\/www.facebook.com\/546410588769082\/posts\/546483102095164","license":"public","citation_ids":[1894230],"posted_on":"2013-11-09T18:09:28+00:00","summary":"HEPATITIS C: REVIEWING THE OPTIONS\nMichal R. Pijak\n\nAs Tom Wong and Samuel Lee mention in their article about hepatitis C,1 patients with genotype 2 or 3 \u201care expected to have a high likelihood of treatment success\u201d; however, the conclusion that these pati","author":{"name":"Michal Pij\u00e1k, MD -  Integrative Hepatology","url":"https:\/\/www.facebook.com\/546410588769082","facebook_wall_name":"Michal Pij\u00e1k, MD -  Integrative Hepatology","image":"https:\/\/graph.facebook.com\/546410588769082\/picture","id_on_source":"546410588769082"}},{"title":"Hepatitis C: reviewing the options","url":"https:\/\/www.facebook.com\/546410588769082\/posts\/556670587743082","license":"public","citation_ids":[1894230],"posted_on":"2013-12-01T20:22:54+00:00","summary":"HEPATITIS C: REVIEWING THE OPTIONS\nMichal R. Pijak, CMAJ July 4, 2006 vol. 175 no. 1","author":{"name":"Michal Pij\u00e1k, MD -  Integrative Hepatology","url":"https:\/\/www.facebook.com\/546410588769082","facebook_wall_name":"Michal Pij\u00e1k, MD -  Integrative Hepatology","image":"https:\/\/graph.facebook.com\/546410588769082\/picture","id_on_source":"546410588769082"}}]}}